Protein tyrosine phosphatase non-receptor type 22 (PTPN22) is the third major locus affecting risk of type I diabetes (T1D), after HLA-DR/DQ and INS. The most associated single-nucleotide polymorphism (SNP), rs2476601, has a C-4T variant and results in an arginine (R) to tryptophan (W) amino acid change at position 620. To assess whether this, or other specific variants, are responsible for T1D risk, the Type I Diabetes Genetics Consortium analyzed 28 PTPN22 SNPs in 2295 affected sib-pair (ASP) families. Transmission Disequilibrium Test analyses of haplotypes revealed that all three haplotypes with a T allele at rs2476601 were overtransmitted to affected children, and two of these three haplotypes showed statistically significant overtransmission (P ¼ 0.003 to P ¼ 5.9E-12). Another haplotype had decreased transmission to affected children (P ¼ 3.5E-05). All haplotypes containing the rs2476601 T allele were identical for all SNPs across PTPN22 and only varied at centromeric SNPs. When considering rs2476601 'C' founder chromosomes, a second haplotype (AGGGGC) centromeric of PTPN22 in the C1orf178 region was associated with protection from T1D (odds ratio ¼ 0.81, P ¼ 0.0005). This novel finding requires replication in independent populations. We conclude the major association of PTPN22 with T1D is likely due to the recognized non-synonymous SNP rs2476601 (R620W).
Introduction
Protein tyrosine phosphatase non-receptor type 22 (PTPN22) is the third major locus recognized to affect type I diabetes (T1D) risk, after HLA-DR/DQ and the insulin gene (INS).
1,2 The lymphoid-specific phosphatase (LYP) encoded by the PTPN22 gene on chromosome 1p13 is an excellent candidate for T1D because it is involved in downregulating T-cell activation. 3 A single-nucleotide polymorphism (SNP, rs2476601, C-T) results in a substitution of arginine (R) by tryptophan (W) residue at LYP codon 620 (R620W) with the tryptophan variant showing greater inhibition of T-cell receptor signaling. 1, 4 Of note, this 'gain of function' tryptophan variant is associated with T1D risk.
Although the minor allele frequency (MAF) of rs2476601 varies widely across ethnic groups, the association of R620W with T1D has been confirmed in several populations. [5] [6] [7] [8] [9] In a haplotype-based analysis of the PTPN22 locus, the 1858T risk allele (rs2476601) occurred on a single haplotype that was strongly associated with T1D. 10, 11 Although R620W is a functional variant, it also maps to an extended linkage disequilibrium (LD) block containing numerous polymorphisms, raising the possibility that other potential functional variants could be responsible for the association with T1D. 8 The PTPN22 rs2476601 SNP is also known to be associated with risk of other autoimmune disorders, including Graves' disease, 5, 12 rheumatoid arthritis, 13 and systemic lupus erythematosus. 14 The 1858T variant has recently been reported to affect the progression from preclinical to clinical diabetes in ICA þ individuals 15 and to confer an additive effect on GAD positivity, 16 further supporting an early and general function for this variant in autoimmunity.
The Type I Diabetes Genetics Consortium (T1DGC) genotyped 2295 affected sib-pair (ASP) families for 28 SNPs across the PTPN22 region on two genotyping platforms (Illumina and Sequenom). This collection of ASP families and genotyping provides a basis to assess which specific PTPN22 SNPs and haplotypes are associated with T1D risk.
Results
Transmission Disequilibrium Test (TDT) analyses showed that 17 out of the 26 Illumina-typed SNPs were significantly associated with T1D. The PTPN22 SNP rs2476601 had the most strong association with T1D, resulting in a relative risk of 1.55 (P ¼ 5.5E-17) (Figure 1a) . TDT analyses using haplotypes of all 27 SNPs (26 Illumina SNPs and 1 Sequenom SNP not typed in Illumina) provided a total of 25 haplotypes with frequency 40.1% (Table 1 ). All three haplotypes with a T allele at rs2476601 were overtransmitted (57-85%, compared with the expected of 50%). Further, 2 of these 3 haplotypes were significantly overtransmitted to affected children (P ¼ 0.003 to P ¼ 5.9E-12). Another haplotype had decreased transmission to affected children (P ¼ 3.5E-05). All T-allele haplotypes were identical for all SNPs across the PTPN22 gene and only varied centromeric of PTPN22 in the C1orf178 (chromosome 1 open reading frame 178) region. Indeed, the LD plot of this region exhibits strong LD for multiple SNPs, with evidence for two haplotype blocks (Figure 1b) . The first haplotype block includes the telomeric region with the RSBN1 (round spermatid basic protein 1) and PTPN22 genes and the second haplotype block includes the centromeric region with C1orf178. A chromosomal map of the 28 SNPs in and near PTPN22 gene is shown in Figure 1c .
Allele frequencies of case and control founder chromosomes (N ¼ 8598) from the 26 Illumina SNPs are shown in Table 2 . To explore the possibility of other PTPN22 SNPs in addition to rs2476601 having an association with T1D, stratified analyses by rs2476601were performed. Additional analyses included using all SNPs in a logistic regression model. Using only PTPN22 rs2476601 'C allele' founder chromosomes (N ¼ 6095), the haplotype AGGGGC, centromeric of PTPN22 in the C1orf178 region, was significantly associated with protection from T1D (odds ratio (OR) ¼ 0.81, 95% confidence interval (CI) ¼ 0.72-0.91, P ¼ 0.0005). Another haplotype, CGAAAC in the C1orf178 region, was associated with susceptibility to T1D (OR ¼ 1.24, 95% CI ¼ 1.02-1.51, P ¼ 0.03) ( Table 3) . For PTPN22 rs2476601 'T allele' founder chromosomes, the LD was almost complete, such that there was minimal effect of other SNPs. Logistic regression analyses in founder chromosomes revealed that only rs2476601 was associated with susceptibility to T1D (OR ¼ 1.27, 95% CI ¼ 1.15-1.41, Po0.0001) whereas three centromeric SNPs (rs7524200, rs1217423, and rs1539438) had evidence for protection (OR ¼ 0.11-0.30, 95% CI ¼ 0.01-0.95, P ¼ 0.03-0.04).
The PTPN22 rs2488457 SNP has been earlier associated with T1D. Stratified analyses by rs2476601 did not show an independent association of rs2488457 with T1D risk. For rs2476601 'C allele' founder chromosomes, the MAF (C allele) for rs2488457 was 12.3% in T1D cases and 12% in non-cases, whereas for rs2476601 'T-allele' chromosomes, the MAF for rs2488457 was 98.9% in cases and 100% in non-cases.
Analyses performed only in probands indicated that the PTPN22 T/T and C/T genotypes occurred more frequently in cases without the HLA DR3/4-DQ8 genotype than in cases carrying the high-risk HLA DR3/4-DQ8 genotype. Frequencies for the T/T genotype were 3.6% in HLA non-DR3/4-DQ8 cases and 3.2% in HLA DR3/4-DQ8 cases. Similarly, the frequencies for the C/T genotype were 29.9% in HLA non-DR3/ 4-DQ8 cases and 22.5% in HLA DR3/4-DQ8 cases (P ¼ 0.001).
Discussion
Despite consistent association observed between the PTPN22 1858C/T polymorphism (R620W) and T1D risk in multiple populations, it is difficult to absolutely define the etiologic polymorphism because of strong LD. To address this question, the coding region of the PTPN22 gene has been sequenced and several novel variants identified. 10 Haplotype analyses suggested that the 1858T risk allele is contained in only one haplotype, which was strongly associated with T1D. After controlling for this haplotype, two other haplotypes were weakly associated with T1D, suggesting that the 1858 SNP or a SNP in strong LD with the 1858 SNP may be responsible for the observed association.
In Asians, the 1858T allele has not been observed. 6, 17 Through extensive sequencing of the PTPN22 coding and regulatory regions, a number of other SNPs have been identified. 11, 17 A regulatory SNP (À1123G/C; rs2488457) was shown to be weakly associated with T1D in Japanese and Koreans, 17 but it was not associated with disease in Sardinians. 11 Recently, 46 SNPs were genotyped in the PTPN22 region in 3000 T1D cases and 2400 controls. 18 In this population, it was concluded that no other PTPN22 SNP was associated with T1D independent of rs2476601. Thus, rs2476601 remains the best candidate as the causal variant in this chromosome region in European populations.
In this T1DGC dataset, we found that all three haplotypes having a T allele at rs2476601 were overtransmitted (57-85%) to affected children. Two of these haplotypes had significant overtransmission (P ¼ 0.003 to P ¼ 5.9E-12), whereas another haplotype (with 'AGGGGC' in the C1orf178 region) was protective. These data are consistent with the possibility that the observed association of PTPN22 with T1D risk may be due to the non-synonymous SNP, rs2476601, as haplotypes bearing the T allele at this SNP are overtransmitted. However, in this data set, all of these haplotypes have identical SNP genotypes across the PTPN22 gene (due to strong LD). Thus, it remains possible that other SNPs may be responsible for the association with T1D. Among chromosomes with the low risk 1858C allele, a second haplotype in the C1orf178 region centromeric of PTPN22 (AGGGGC) exhibits a strong association with T1D, with decreased transmission to patients. This finding requires replication in independent populations.
In these T1DGC ASP families, the PTPN22 rs2476601 T/ T and C/T genotypes were significantly more frequent in T1D cases carrying lower risk HLA genotypes (that is without the HLA-DR3/4-DQ8 genotype), a finding that is consistent with a recent study. 18 The PTPN22 rs2476601 SNP results in a missense mutation that changes an arginine (R) at position 620 to a tryptophan (W) and abrogates the ability of the molecule to bind to the signaling molecule Csk (c-Src tyrosine kinase). 1, 3 The lyp-Csk complex down-regulates T-cell receptor signaling, and the T1D-associated variant is reported to result in greater inhibition of T-cell receptor signaling. 4, 19, 20 Consistent with an early and general effect on immune function is the finding that the minor tryptophan-encoding allele is associated with a series of autoimmune disorders, including rheumatoid arthritis, systemic lupus erythematosus, rs2476601 T allele (R620W) defines high-risk PTPN22 T1D-associated haplotypes AK Steck et al S23 autoimmune thyroid disease (either Hashimoto thyroiditis or Graves' disease), and T1D with an overall OR for the T allele between 1.5 and 1.9. 21 Others have shown that rs2476601 regulates T1D-specific autoimmunity and strongly affects the progression from preclinical to clinical diabetes in ICA positive individuals.
15 Abbreviations: SNP, single-nucleotide polymorphism; TDT, Transmission Disequilibrium Test. The three haplotypes with a T allele at rs2476601 are highlighted in bold for the SNPs that are identical across the PTPN22 gene. The arrow points to rs2476601 (SNP number 9). The association of PTPN22 with T1D is likely due to the non-synonymous SNP rs2476601. All haplotypes with a T allele at this SNP have identical alleles for all SNPs telomeric and across the PTPN22 gene. For haplotypes with the C allele at rs2476601, we provide initial evidence for an additional locus influencing T1D.
Materials and methods

Study population
The T1DGC has created a resource base of wellcharacterized families from multiple ethnic groups to facilitate the localization and characterization of T1D susceptibility genes (http://www.t1dgc.org). Genotyping for the Rapid Response project was performed on 2295 families in nine cohorts. SNPs in 21 candidate genes were genotyped on two platforms (Illumina and Sequenom). Details of the sample, quality control, and other aspects of the data can be found in this volume (Brown et al. 22 ). The families selected for these analyses consisted mainly of nuclear families with an ASP. This study reports the results for the 28 SNPs genotyped across the PTPN22 region in 9251 individuals, including 5580 children (4445 (80%) affected, 840 (15%) unaffected, 295 (5%) unknown status) and 3671 parents (157 (4%) affected, 2576 (70%) unaffected, 938 (26%) unknown status). There was no significant difference by sex (male/ female ¼ 49.4%). The average age of onset of T1D for cases was 11.5 years (range, 0-71 years) with an average duration of disease of 13 years (range, 0-63 years). The families used in this study were collected from the following T1DGC networks and contributing sites: 9% Asia-Pacific, 29% European, 35% North American, and 27% UK/Sardinian. The majority of the subjects were Caucasian (81%) with 18% unknown ethnicity and 1% other (Asian, African American, Pacific Islander).
Genotyping
The T1DGC has genotyped 2295 ASP families for 28 SNPs across the PTPN22 region using both Illumina and Sequenom platforms. A total of 26 SNPs were genotyped by Illumina GoldenGate technology, whereas 25 SNPs were genotyped by Sequenom MALDI-TOF technology, for a total of 23 SNPs genotyped on both platforms. The call rate for all SNPs in both platforms was complete (497% call rate except for 3 SNPs which had a slightly lower call rate of 93-96%) and concordant between the two platforms (498% concordance except for 1 SNP which had a 96% concordance rate). All SNPs were in Hardy-Weinberg equilibrium except for one SNP (rs1746860) from the Sequenom platform, which was therefore excluded from all analyses. Of the 28 SNPs, 11 are in the PTPN22 gene, including the nonsynonymous R620W SNP, and 9 are in known neighboring genes, including 4 in the RSBN1 gene and 5 in the C1orf178 which encodes Bfk, a B-cell lymphoma 2 (BCL2) family member (BFK) with some proapoptotic effects that is expressed in both spleen and thymus (Figure 1c) . 23 Statistical analysis Data quality checks, using standard methods including the PedCheck program, and TDT for individual SNPs using the UNPHASED software (v 2.40). were performed by the Coordinating Center of the T1DGC. The LD plot and TDT analyses for the haplotypes were computed using Haploview software (http:// www.broad.mit.edu/mpg/haploview). 24 For the TDT haplotype analyses, we converted the families to trios, by including parents and one single, randomly chosen offspring. We repeated TDT analyses with the second affected offspring to account for the transmissions to the other affected sibling and combined both datasets for analyses.
Merlin software (http://www.sph.umich.edu/csg/ abecasis/Merlin) 25 was used to phase the SNP genotype data from families into haplotypes. AFBAC (affected family-based control) methodology was used to assign case or control status to chromosomes, 26 using a VBA (Visual Basic for Applications) program developed inhouse. SAS software version 9.1 (http://www.SAS.com) was used to perform logistic regression analysis. Results were considered significant at ao0.05 without adjustments for multiple comparisons. Stratified analyses by rs2476601 looking at only rs2476601 'C' founder chromosomes (N ¼ 6095).
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